Skip to content
BiologicalX

Comparison

Magnesium Glycinate vs Modafinil

Side-by-side of Magnesium Glycinate and Modafinil. Every row below is pulled from the compound schema and will update as our data grows. For deeper reads, follow through to each compound page.

Effects at a glance

Magnesium Glycinate

  • Shortens sleep onset latency in older adults and in deficient populations supplementing 200 to 400 mg elemental Mg
  • Improves subjective sleep quality scores (PSQI, ISI) modestly versus placebo over 4 to 8 weeks
  • Reduces nocturnal leg cramps and exercise-induced muscle cramping in some controlled trials
  • Lowers self-reported anxiety in mild-to-moderate cases, with smaller effect than first-line pharmacotherapy
  • Glycinate form delivers fewer GI side effects than oxide or citrate at equivalent elemental doses
  • Insufficient as a stand-alone hypertension treatment; small adjunctive blood-pressure reductions only

Modafinil

  • FDA approved in 1998 for narcolepsy, with later additions for shift-work sleep disorder and OSA residual sleepiness
  • Schedule IV controlled substance in the US; prescription-only in EU, UK, Australia
  • Increases wakefulness via weak dopamine reuptake inhibition plus histaminergic, noradrenergic, and orexinergic activation
  • Long half-life of 12 to 15 hours requires morning dosing to avoid sleep disruption
  • Modest cognitive enhancement signal in non-sleep-deprived adults at 100 to 200 mg (Battleday meta-review 2015)
  • Substantial CYP3A4 induction reduces hormonal contraceptive efficacy; barrier methods recommended

Side-by-side

Attribute Magnesium Glycinate Modafinil
Category supplement pharmaceutical
Also known as magnesium bisglycinate Provigil, Modalert, Modvigil, diphenylmethylsulfinyl-acetamide
Half-life (hr) 5 13
Typical dose (mg) 300 200
Dosing frequency daily (often evening) daily, morning
Routes oral oral
Onset (hr) 1 1
Peak (hr) - 3
Molecular weight - 273.35
Molecular formula - C15H15NO2S
Mechanism Magnesium acts as a cofactor for 300+ enzymes and as a voltage-dependent antagonist at NMDA receptors; glycine serves as an inhibitory neurotransmitter and co-agonist at glycine receptors. Weak dopamine reuptake inhibition plus downstream activation of histaminergic, noradrenergic, and orexinergic wake-promoting systems.
Legal status Dietary supplement Schedule IV (US); prescription-only globally; not a supplement
WADA status allowed banned
DEA / Rx OTC supplement Schedule IV
Pregnancy Generally considered acceptable at RDA doses; consult clinician Not recommended
CAS 14783-68-7 68693-11-8
PubChem CID 84645 4236
Wikidata - Q422968

Safety profile

Magnesium Glycinate

Common side effects

  • mild GI upset at high doses
  • loose stools (dose-dependent, less than with oxide/citrate forms)

Contraindications

  • severe renal impairment
  • myasthenia gravis
  • heart block

Interactions

  • tetracycline and fluoroquinolone antibiotics: magnesium chelates antibiotic, reducing absorption; separate by 2+ hours(moderate)
  • bisphosphonates: reduced absorption of bisphosphonate(moderate)
  • potassium-sparing diuretics: possible hypermagnesemia in renal impairment(moderate)

Modafinil

Common side effects

  • headache
  • nausea
  • anxiety
  • insomnia (with late-day dosing)
  • dry mouth
  • mild blood pressure elevation

Contraindications

  • recent myocardial infarction
  • unstable angina
  • left ventricular hypertrophy
  • significant arrhythmia
  • history of Stevens-Johnson syndrome
  • psychotic disorders
  • pregnancy
  • concurrent MAOI use

Interactions

  • hormonal contraceptives: CYP3A4 induction reduces contraceptive efficacy; use barrier method(major)
  • cyclosporine: reduced cyclosporine levels via CYP3A4 induction(major)
  • warfarin: CYP2C9 inhibition raises INR(moderate)
  • phenytoin: CYP2C19 inhibition raises phenytoin levels(moderate)
  • MAOIs: potential hypertensive reaction(major)
  • classical stimulants (amphetamine, methylphenidate): additive cardiovascular and sleep-disruption effects(moderate)

Which Should You Take?

Magnesium Glycinate comes out ahead for most readers on the criteria we weight: 3 catalogued goals, OTC dietary supplement, oral dosing, with a Tier-A outcome catalogued. Modafinil is the right call when one of the conditionals below applies.

Edge case: If you want to avoid controlled substance, Magnesium Glycinate is the more accessible choice.

Default choice: Magnesium Glycinate. Lower friction to source, a Tier-A evidence outcome catalogued, and broader goal coverage. Reach for Modafinil only if your priority sits squarely in the goals it owns above.

This verdict is generated from each compound's schema (goals, legal status, evidence outcomes, dosing route). It updates automatically as our compound data evolves; the deeper read sits on each individual compound page.

Common questions

What is the difference between Magnesium Glycinate and Modafinil?

Magnesium Glycinate and Modafinil differ in category (supplement vs pharmaceutical), mechanism, and typical dosing. See the side-by-side table for full details.

Which has a longer half-life, Magnesium Glycinate or Modafinil?

Magnesium Glycinate half-life is 5 hours; Modafinil half-life is 13 hours.

Can you stack Magnesium Glycinate with Modafinil?

Stack compatibility depends on mechanism overlap, legal status, and individual response. Check each compound page for specific interactions and contraindications before combining.

Go deeper